PDGFRB and osteosarcoma: Additionally, organoids of both non-metastatic and metastatic osteosarcoma were constructed, and immunohistochemistry and multicolor immunofluorescence techniques were employed to validate the distributional characteristics, expression, and ligand-receptor binding of PDGFD and PDGFRB.